{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":61,"n_cols":5,"rows_kept":61,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[8,2,8,3],[9,2,9,3],[10,2,10,3],[11,2,11,3],[54,2,54,3],[55,2,55,3],[58,2,58,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910139903203321"]
[null,null,"Titolo",null,"A Practical Handbook on the Pharmacovigilance of Antimalarial Medicines"]
[null,null,"Pubbl/distr/stampa",null,"Geneva, : World Health Organization, 2008"]
[null,null,"ISBN",null,"9786612250057"]
[{"$nulls":4},"9781282250055"]
[{"$nulls":4},"1282250051"]
[{"$nulls":4},"9789240683716"]
[{"$nulls":4},"9240683712"]
[null,null,"Edizione",null,"[1st ed.]"]
[null,null,"Descrizione fisica",null,"1 online resource (175 p.)"]
[null,null,"Disciplina",null,"600"]
[null,null,"Soggetti",null,"Adverse Drug Reaction Reporting Systems"]
[{"$nulls":4},"Antimalarials -- standards"]
[{"$nulls":4},"Antimalarials"]
[{"$nulls":4},"Drug Monitoring"]
[{"$nulls":4},"Drug Utilization Review -- methods"]
[{"$nulls":4},"Pharmacoepidemiology -- methods"]
[{"$nulls":4},"Product Surveillance, Postmarketing"]
[{"$nulls":4},"Drug monitoring - Side effects"]
[{"$nulls":4},"Drug Utilization Review"]
[{"$nulls":4},"Pharmacoepidemiology"]
[{"$nulls":4},"Methods"]
[{"$nulls":4},"Utilization Review"]
[{"$nulls":4},"Antiprotozoal Agents"]
[{"$nulls":4},"Investigative Techniques"]
[{"$nulls":4},"Drug Utilization"]
[{"$nulls":4},"Pharmacology"]
[{"$nulls":4},"Epidemiology"]
[{"$nulls":4},"Evaluation Studies as Topic"]
[{"$nulls":4},"Monitoring, Physiologic"]
[{"$nulls":4},"Quality of Health Care"]
[{"$nulls":4},"Quality Assurance, Health Care"]
[{"$nulls":4},"Public Health"]
[{"$nulls":4},"Health Occupations"]
[{"$nulls":4},"Biological Science Disciplines"]
[{"$nulls":4},"Analytical, Diagnostic and Therapeutic Techniques and Equipment"]
[{"$nulls":4},"Diagnostic Techniques and Procedures"]
[{"$nulls":4},"Pharmacy Administration"]
[{"$nulls":4},"Antiparasitic Agents"]
[{"$nulls":4},"Disciplines and Occupations"]
[{"$nulls":4},"Medicine"]
[{"$nulls":4},"Health Services Administration"]
[{"$nulls":4},"Natural Science Disciplines"]
[{"$nulls":4},"Health Care Quality, Access, and Evaluation"]
[{"$nulls":4},"Organization and Administration"]
[{"$nulls":4},"Diagnosis"]
[{"$nulls":4},"Anti-Infective Agents"]
[{"$nulls":4},"Therapeutic Uses"]
[{"$nulls":4},"Delivery of Health Care"]
[{"$nulls":4},"Pharmacologic Actions"]
[{"$nulls":4},"Chemical Actions and Uses"]
[{"$nulls":4},"Chemicals and Drugs"]
[{"$nulls":4},"Pharmacy, Therapeutics, & Pharmacology"]
[{"$nulls":4},"Health & Biological Sciences"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,"Nota di contenuto",null,"COVER; TITLE; COPYRIGHT; TABLE OF CONTENTS; FOREWORD; PART 1: GUIDANCE DOCUMENT ON CHARACTERIZING AND COMMUNICATING UNCERTAINTY IN EXPOSURE ASSESSMENT; ACKNOWLEDGEMENTS; MEMBERS OF THE WHO/IPCS WORKING GROUP ON UNCERTAINTY IN EXPOSURE ASSESSMENT; LIST OF ACRONYMS AND ABBREVIATIONS; EXECUTIVE SUMMARY; 1. INTRODUCTION; 2. CONTEXT, CONCEPTS AND DEFINITIONS; 3. SOURCES OF UNCERTAINTY; 4. TIERED APPROACH TO UNCERTAINTY ANALYSIS; 5. UNCERTAINTY CHARACTERIZATION METHODS, INTERPRETATION AND USE; 6. COMMUNICATION; 7. CONCLUSIONS; 8. REFERENCES; GLOSSARY OF TERMS"]
[{"$nulls":4},"ANNEX 1: CASE-STUDY-QUALITATIVE UNCERTAINTY ANALYSISAppendix 1: Background for case-study; ANNEX 2: CASE-STUDY-QUANTITATIVE UNCERTAINTY ANALYSIS; PART 2: HALLMARKS OF DATA QUALITY IN CHEMICAL EXPOSURE ASSESSMENT; PREPARATION OF THE DOCUMENT; 1. INTRODUCTION; 2. WHAT DO WE MEAN BY \"DATA\" IN EXPOSURE ASSESSMENT?; 3. TOWARDS A BROADER DEFINITION OF QUALITY IN EXPOSURE ASSESSMENT: HALLMARKS OF DATA QUALITY; 4. FROM EXPOSURE DATA QUALITY TO THE QUALITY OF EXPOSURE ASSESSMENTS; 5. CONCLUSIONS; 6. REFERENCES; Back Cover"]
[null,null,null,"Sommario/riassunto","\"\"The Handbook\"\" is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antimalarials. It is intended to be a source of practical advice for pharmacovigilance centres. It provides information on spontaneous reporting of adverse drug reactions as a complement to other WHO publications. In addition, it provides details on how to conduct cohort event monitoring, which is a method of active safety surveillance collecting information on all adverse events occurring after treatment. It also details how to perform causality assessment and signal identification, ap"]